APLT - Applied Therapeutics GAAP EPS of -$1.42 beats by $0.02 revenue of $10M misses by $0.67M
2024-03-06 07:31:25 ET
More on Applied Therapeutics
- Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible
- Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade)
- ARISE-HF Phase 3 Trial Likely To Disappoint Due To Multiple Red Flags
- Applied Therapeutics hits 52-week high on trial success
- Applied Therapeutics gains as late-stage trial for lead asset succeeds